TIRZEPATIDE : A COMPARATIVE LOOK

The novel class of GLP-1 receptor agonist and GIP combined medications, including tirzepatide, semaglutide, and the recently introduced retatrutide, offer promising advances in metabolic treatment . While all three work by impacting glucose readings , they differ in their unique mechanisms of eff